Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis.
Ann Med. 2022 Dec;54(1):516-523. doi: 10.1080/07853890.2022.2034936.
Ann Med. 2022.
PMID: 35118917
Free PMC article.